On 7 May 2024, the EU Medicines Agency (EMA) withdrew marketing authorisation (MA) approval for AZ’s COVID-19 vaccine Vaxzevria, at AZ’s request. AZ requested the withdrawal reportedly due to decline in demand for the vaccine and it no longer being manufactured or supplied.
Vaxzevria was co-developed with Oxford University as a Covid-19 vaccine and was manufactured by CSL. Vaxzevria was granted conditional MA for immunisation against Covid-19 on 29 January 2021 and then granted a 5-year standard MA on 31 October 2022. According to CNN Business, AZ has supplied more than 3 billion vaccine doses globally since 2021.